So the defensible position on BPC-157 vs TB-500 is that both show reproducible, mechanistically interesting healing and angiogenic effects in preclinical systems, but neither has demonstrated safety or efficacy in adequately powered human trials
Intravenous administration bypasses this limitation but requires medical supervision, carries infection risk, and lacks robust efficacy data for skin lightening in published trials
9,10 Detecting changes in the expression and activity of these molecules is essential for further investigation of ferroptosis
Most patients return to normal activities immediately after treatment
However, both the mechanism and degree of respiratory inhibition are dependent on intracellular oxygen concentration and the redox state of CIV (Figure 5) (Taylor and Moncada, 2010)
A blog post from someone caught up in the Pruitt retractions makes the point that journals that insisted on full data deposits for publication were well ahead of those that hadnt (Bolnick, 2021)